Literature DB >> 9086286

A model of myocardial ischemia for the simultaneous assessment of electrophysiological changes and arrhythmias in intact rabbits.

T D Barrett1, B A MacLeod, M J Walker.   

Abstract

A method of recording epicardial monophasic action potentials (MAPs) and ischemia-induced arrhythmias following coronary artery ligation in intact rabbits is described. It is expected that this model will have utility in analyzing drug effects and mechanisms of ischemic arrhythmogenesis. Rabbits were found to have two arrhythmic phases following coronary artery occlusion which correspond to phase Ia and Ib arrhythmias in other species. Epicardial MAPs recorded from ischemic tissue allowed electrophysiological effects to be correlated with these phases. Phase Ia arrhythmias occurred within the first 2 min of coronary artery occlusion and were associated with a reduction in the maximum upstroke velocity of MAPs and changes in MAP duration, including the occurrence of alternans in duration. Phase Ib arrhythmias occurred between 8 and 15 min after coronary artery occlusion. These arrhythmias were associated with a decrease in MAP duration and amplitude, alternans in MAP duration as well as conduction block. Coronary artery occlusion reliably induced arrhythmias in rabbits if the left branch of the coronary artery and the left anterior descending artery were occluded. There was a 95% incidence of premature ventricular contractions, 38% of ventricular tachycardia, and 48% of ventricular fibrillation (n = 21). The results of this study show that epicardial MAPs can be used to aid in the characterization of the electrophysiological mechanisms of ischemia-induced arrhythmias in vivo.

Entities:  

Mesh:

Year:  1997        PMID: 9086286     DOI: 10.1016/s1056-8719(96)00145-1

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  6 in total

1.  Potentiation of halofantrine-induced QTc prolongation by mefloquine: correlation with blood concentrations of halofantrine.

Authors:  I D Lightbown; J P Lambert; G Edwards; S J Coker
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

2.  Molecular analysis of the Na+ channel blocking actions of the novel class I anti-arrhythmic agent RSD 921.

Authors:  M K Pugsley; A L Goldin
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

3.  RSD1019 suppresses ischaemia-induced monophasic action potential shortening and arrhythmias in anaesthetized rabbits.

Authors:  T D Barrett; B A MacLeod; M J Walker
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

4.  Potentiation of E-4031-induced torsade de pointes by HMR1556 or ATX-II is not predicted by action potential short-term variability or triangulation.

Authors:  G Michael; J Dempster; K A Kane; S J Coker
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

5.  The persistent sodium current blocker riluzole is antiarrhythmic and anti-ischaemic in a pig model of acute myocardial infarction.

Authors:  Steven M Weiss; David A Saint
Journal:  PLoS One       Date:  2010-11-24       Impact factor: 3.240

6.  Rabbit-specific computational modelling of ventricular cell electrophysiology: Using populations of models to explore variability in the response to ischemia.

Authors:  Philip Gemmell; Kevin Burrage; Blanca Rodríguez; T Alexander Quinn
Journal:  Prog Biophys Mol Biol       Date:  2016-06-16       Impact factor: 3.667

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.